Discussion and Q&A - Vienna 2024 - ERS Respiratory Channel

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Vienna 2024 Discussion and Q&A

Should advancing age and comorbidities prevent you from initiating antifibrotic therapy?

Chair(s): Katerina Antoniou, Ioannis Vogiatzis

Session type: Pro-Con debate

Discussion and Q&A

EVENTS HOME

Replay

Previous presentation

Next presentation

Session content

Pro: I would start antifibrotic therapy in an 80-year-old with comorbidities

Nazia Chaudhuri

Replay

Slides

Con: I would not start antifibrotic therapy in an 80-year-old with comorbidities

George Margaritopoulos

Replay

Slides

Discussion and Q&A

Replay

Session aims

To highlight some of the emerging themes and controversies regarding the early treatment of interstitial lung diseases; to discuss the common clinical dilemmas and misconceptions that occur in clinical practise regarding the influence of age and comorbidities on the decision to start anti-inflammatory or antifibrotic treatment; to explore the role of risk stratification and early treatment in connective tissue diseases.

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}